| Acceleration of distraction osteogenesis with drug-releasing distractor E Konas, ME Mavili, P Korkusuz, D Demir, F Öner, HI Canter Journal of Craniofacial Surgery 20 (6), 2041-2048, 2009 | 19 | 2009 |
| The efficacy of negative pressure wound therapy on chemotherapeutic extravasation ulcers: An experimental study E Isci, HI Canter, M Dadaci, P Atilla, AN Cakar, A Kecik Indian Journal of Plastic Surgery 47 (03), 394-400, 2014 | 9 | 2014 |
| A new concept in treatment of burn injury: controlled slow-release granulocyte-monocyte colony-stimulating factor chitosan gel system S Simsek, HI Canter, E Konas, P Korkusuz, D Demir, F Oner, I Unsal, ... Annals of plastic surgery 67 (6), 583-588, 2011 | 7 | 2011 |
| An alternative rapid method for transformation of Escherichia coli D Demir, T Kocagöz, F Öner FABAD J. Pharm. Sci 29, 7-13, 2004 | 6 | 2004 |
| Additive cell protective and oxidative stress reducing effects of combined treatment with cromolyn sodium and masitinib on MPTP-induced toxicity in SH-SY5Y neuroblastoma cells AYG Erol, FG Kocanci, D Demir-Dora, H Uysal Chemico-Biological Interactions 354, 109808, 2022 | 4 | 2022 |
| A new concept in the treatment of extravasation injury: Controlled drug delivery systems E Konas, HI Canter, P Korkusuz, D Demir, F Oner, ME Mavili J BUON 15, 592-600, 2010 | 3 | 2010 |
| Optimizing bacterial transformation in the pDNA-cationic lipid-surfactant complex systems by adjusting CaCl2 concentration and incubation temperature D DEMİR, AF ÖNER, T KOCAGÖZ FABAD Journal of Pharmaceutical Sciences 27 (1), 7-11, 2002 | 3 | 2002 |
| Gut Microbiota: Formation, Lifelong Development and Relation to Cytochrome P450 System, Diseases, Drug Bioavailability and Drug Interactions B Cesur, DD Dora European Journal of Therapeutics 26 (4), 344-349, 2020 | 1 | 2020 |
| Biyolojik olmayan kompleks ilaçlar B CESUR, D DEMİR-DORA Türk Hijyen ve Deneysel Biyoloji Dergisi 76 (2), 221-228, 2018 | 1 | 2018 |
| Development of novel precirol based cationic solid lipid nanoparticles by microemulsion dilution method as DNA delivery system M Kotmakchiev, H Akbaba, DD Dora, C Korkmaz, G Kantarci Current Opinion in Biotechnology, S129, 2011 | 1 | 2011 |
| Gene Delivery to Triple-Negative Breast Cancer Cells by Folic Acid-Polyethyleneimine Polyplexes DD DORA Fabad Journal of Pharmaceutical Sciences 48 (3), 469-480, 2023 | | 2023 |
| Construction of a lentiviral vector-carrying SARS-CoV-2 spike gene for COVID-19 F Erendor, EO Sahin, B Akkaya, A Bisgin, DD Dora, S Koksoy, HB Oral, ... HUMAN GENE THERAPY 32 (19-20), A100-A100, 2021 | | 2021 |
| Biyobenzer tıbbi ürünlerin üretim süreci ve kalitesinin güvenlilik ve etkililik üzerine etkisi DD Dora Ege Tıp Dergisi, 77-82, 2021 | | 2021 |
| Masitinib mediates TGF-Beta1 and Nitric Oxide Secretion and Ameliorates MPTP/Microglia-Induced Degeneration of Differentiated SH-SY5Y Cells AY Göksu Erol, E Akıncı, FG Koçancı, F Akçakale, DD Dora, H Uysal bioRxiv, 2020.07. 16.206094, 2020 | | 2020 |
| Liquid versus Semi-Solid Culture Medium for Differentiation of Human Mast Cells from Hematopoietic Stem Cells in Bone Marrow AY Goksu-Erol, E Akinci, H Uysal, DD Dora, O Salim JOURNAL OF CLINICAL IMMUNOLOGY 40 (SUPPL 1), S33-S34, 2020 | | 2020 |
| Development of nano-sized non-viral DNA delivery system for gene therapy purposes B Cesur, D Dora, E Demir HUMAN GENE THERAPY 30 (11), A203-A203, 2019 | | 2019 |
| The effects of lyophilization and cryoprotectants on solid lipid nanoparticle-DNA systems H Akbaba, DD Dora, AG KANTARCI Romanian Biotechnological Letters 22 (6), 13186, 2017 | | 2017 |
| Experimental Ischemia/Reperfusion Model in Relation to Apototic Cell Death M Emre, S Demirkol, DD Dora, I Unlukurt, Z Topcu, G Ozsarlak‐Sozer The FASEB Journal 27, lb861-lb861, 2013 | | 2013 |
| Determining complexation parameters of plasmid DNA and solid lipid nanoparticles to compose optimal complexes for in vitro transfection H Akbaba, G Kantarci, DD Dora FEBS JOURNAL 278, 322-322, 2011 | | 2011 |
| Development of genetic competence in Bacillus mojavensis by recombinant ComXRO-B-2 fusion protein for production of recombinant pharmaceutical proteins DD Dora, T Kocagoz, F Oner Current Opinion in Biotechnology, S129, 2011 | | 2011 |
